-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The sixth batch of Guocai is the special quantity procurement of insulin.
The varieties are prandial human insulin, basal human insulin, premixed human insulin, prandial insulin analogs, basal insulin analogs, and premixed insulin analogs, with a total of 6 procurement groups.
.
According to the work arrangement issued by the National Organization of Drug Joint Purchasing Office on January 6, 2022, from May 2022, the results of the sixth batch of national centralized drug procurement (insulin special) will be officially implemented.
The specific implementation date is subject to the announcements issued by local governments
.
Judging from the information disclosed in various places, the sixth batch of national mining may still be implemented in May this year! For example, on April 11, the Hainan Provincial Medical Insurance Bureau issued the "Pre-Notice on the Implementation of the Recent National and Inter-Provincial Alliance Organizations for the Centralized Procurement of Drugs with Volume", stating that Hainan Province is expected to issue the sixth batch of national centralized procurement (insulin) before the end of April.
Special) implementation plan, and the results of the selection will be officially implemented around the end of May
.
On March 24, Gansu Province issued the "Notice on Carrying out the Maintenance of the Distribution Relationship of the Sixth Batch of Nationally Organized Centralized Drug Procurement (Insulin Special)", and began the preparations for the implementation of the sixth batch of nationally purchased 78 selected drugs.
, to organize and carry out the maintenance of the distribution relationship of the selected drugs in advance, and the specific schedule is from March 23 to April 15, 2022
.
At the same time, the Gansu Provincial Medical Insurance Bureau stated in this notice that the results of the selection will be implemented in May 2022, and the specific requirements are subject to the implementation notice
.
On March 18, the Fujian Provincial Joint Procurement Center for Pharmaceuticals and Equipment also issued a notice to organize the online procurement of the sixth batch of drugs related to national procurement, requiring that the online information be completed by today (27th)
.
According to the plan, it is expected that all provinces and cities will implement the bid in May.
Recently, the Shenzhen Municipal Medical Insurance Bureau also mentioned that the sixth batch of national procurement results will be implemented in May.
The specific implementation date is based on Guangdong.
The Provincial Medical Insurance Bureau will issue a notice
.
According to the sorting out, Henan, Sichuan, Guangdong, Shanghai, Heilongjiang and other places have all issued notices on the work of listing the selected drugs in the sixth batch of nationally sourced (insulin special) online or online reporting
.
However, the recent outbreak of the epidemic has been in a state of high incidence, and some provinces have also released news about the postponement of bulk procurement work.
.
For example, the Liaoning Provincial Public Resource Trading Center issued a notice that due to the severe situation of epidemic prevention and control recently, in accordance with the requirements of epidemic prevention and control work, it was decided to postpone the first and third batches of the national drug centralized procurement agreement in Liaoning Province after the expiration of the agreement (inquiry ) quotation work, the specific time will be notified separately
.
On November 30, 2021, the results of the sixth batch of centralized drug procurement organized by the state (insulin special) were announced.
The average drop of 48% is undoubtedly good news for more than 10 million patients who use insulin
.
According to the rules of centralized procurement, after completing the preparatory work such as hanging the network, the winning result will be officially implemented soon
.
It is reported that a total of 42 products from 11 pharmaceutical companies were selected in this centralized procurement
.
The biggest drop was Eli Lilly's protamine zinc recombinant lispro insulin cord mix (25R), with a drop of about 74%; 27 varieties fell between 40% and 50%, and 15 varieties fell by more than 50%.
.
In addition, according to relevant news, there are 32,000 medical institutions participating in this round of national procurement, and the declared demand for centralized insulin procurement is about 200 million, involving an amount of nearly 17 billion yuan, and the actual agreement procurement volume is about 14 billion yuan
.
Analysts said that once the sixth batch of national procurement landed, the major reshuffle of the insulin market would begin immediately
.
In addition, some people in the industry believe that the special centralized procurement of insulin can promote the replacement of domestic brands, and the market share of domestic insulin will further expand
.
"Testing and Calibration of Dry Body Temperature Calibrators" is about to be broadcast, welcome to sign up Disclaimer: In any case, the information or opinions expressed in this article do not constitute investment advice to anyone
.
The varieties are prandial human insulin, basal human insulin, premixed human insulin, prandial insulin analogs, basal insulin analogs, and premixed insulin analogs, with a total of 6 procurement groups.
.
According to the work arrangement issued by the National Organization of Drug Joint Purchasing Office on January 6, 2022, from May 2022, the results of the sixth batch of national centralized drug procurement (insulin special) will be officially implemented.
The specific implementation date is subject to the announcements issued by local governments
.
Judging from the information disclosed in various places, the sixth batch of national mining may still be implemented in May this year! For example, on April 11, the Hainan Provincial Medical Insurance Bureau issued the "Pre-Notice on the Implementation of the Recent National and Inter-Provincial Alliance Organizations for the Centralized Procurement of Drugs with Volume", stating that Hainan Province is expected to issue the sixth batch of national centralized procurement (insulin) before the end of April.
Special) implementation plan, and the results of the selection will be officially implemented around the end of May
.
On March 24, Gansu Province issued the "Notice on Carrying out the Maintenance of the Distribution Relationship of the Sixth Batch of Nationally Organized Centralized Drug Procurement (Insulin Special)", and began the preparations for the implementation of the sixth batch of nationally purchased 78 selected drugs.
, to organize and carry out the maintenance of the distribution relationship of the selected drugs in advance, and the specific schedule is from March 23 to April 15, 2022
.
At the same time, the Gansu Provincial Medical Insurance Bureau stated in this notice that the results of the selection will be implemented in May 2022, and the specific requirements are subject to the implementation notice
.
On March 18, the Fujian Provincial Joint Procurement Center for Pharmaceuticals and Equipment also issued a notice to organize the online procurement of the sixth batch of drugs related to national procurement, requiring that the online information be completed by today (27th)
.
According to the plan, it is expected that all provinces and cities will implement the bid in May.
Recently, the Shenzhen Municipal Medical Insurance Bureau also mentioned that the sixth batch of national procurement results will be implemented in May.
The specific implementation date is based on Guangdong.
The Provincial Medical Insurance Bureau will issue a notice
.
According to the sorting out, Henan, Sichuan, Guangdong, Shanghai, Heilongjiang and other places have all issued notices on the work of listing the selected drugs in the sixth batch of nationally sourced (insulin special) online or online reporting
.
However, the recent outbreak of the epidemic has been in a state of high incidence, and some provinces have also released news about the postponement of bulk procurement work.
.
For example, the Liaoning Provincial Public Resource Trading Center issued a notice that due to the severe situation of epidemic prevention and control recently, in accordance with the requirements of epidemic prevention and control work, it was decided to postpone the first and third batches of the national drug centralized procurement agreement in Liaoning Province after the expiration of the agreement (inquiry ) quotation work, the specific time will be notified separately
.
On November 30, 2021, the results of the sixth batch of centralized drug procurement organized by the state (insulin special) were announced.
The average drop of 48% is undoubtedly good news for more than 10 million patients who use insulin
.
According to the rules of centralized procurement, after completing the preparatory work such as hanging the network, the winning result will be officially implemented soon
.
It is reported that a total of 42 products from 11 pharmaceutical companies were selected in this centralized procurement
.
The biggest drop was Eli Lilly's protamine zinc recombinant lispro insulin cord mix (25R), with a drop of about 74%; 27 varieties fell between 40% and 50%, and 15 varieties fell by more than 50%.
.
In addition, according to relevant news, there are 32,000 medical institutions participating in this round of national procurement, and the declared demand for centralized insulin procurement is about 200 million, involving an amount of nearly 17 billion yuan, and the actual agreement procurement volume is about 14 billion yuan
.
Analysts said that once the sixth batch of national procurement landed, the major reshuffle of the insulin market would begin immediately
.
In addition, some people in the industry believe that the special centralized procurement of insulin can promote the replacement of domestic brands, and the market share of domestic insulin will further expand
.
"Testing and Calibration of Dry Body Temperature Calibrators" is about to be broadcast, welcome to sign up Disclaimer: In any case, the information or opinions expressed in this article do not constitute investment advice to anyone
.
